Literature DB >> 31075413

Type III collagen (COL3A1): Gene and protein structure, tissue distribution, and associated diseases.

Helena Kuivaniemi1, Gerard Tromp2.   

Abstract

Collagen alpha-1(III) chain, also known as the alpha 1 chain of type III collagen, is a protein that in humans is encoded by the COL3A1 gene. Three alpha 1 chains are required to form the type III collagen molecule which has a long triple-helical domain. Type III collagen, an extracellular matrix protein, is synthesized by cells as a pre-procollagen. It is found as a major structural component in hollow organs such as large blood vessels, uterus and bowel. Other functions of type III collagen include interaction with platelets in the blood clotting cascade and it is also an important signaling molecule in wound healing. Mutations in the COL3A1 gene cause the vascular type of Ehlers-Danlos syndrome (vEDS; OMIM 130050). It is the most serious form of EDS, since patients often die suddenly due to a rupture of large arteries. Inactivation of the murine Col3a1 gene leads to a shorter life span in homozygous mutant mice. The mice die prematurely from a rupture of major arteries mimicking the human vEDS phenotype. The biochemical and cellular effects of COL3A1 mutations have been studied extensively. Most of the glycine mutations lead to the synthesis of type III collagen with reduced thermal stability, which is more susceptible for proteinases. Intracellular accumulation of this normally secreted protein is also found. Ultrastructural analyses have demonstrated dilated rough endoplasmic reticulum and changes in the diameter of collagen fibers. Other clinical conditions associated with type III collagen are several types of fibroses in which increased amounts of type III collagen accumulate in the target organs.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Connective tissue; Ehlers-Danlos syndrome; Extracellular matrix; Fibrosis; Vascular disease

Mesh:

Substances:

Year:  2019        PMID: 31075413      PMCID: PMC6579750          DOI: 10.1016/j.gene.2019.05.003

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  166 in total

1.  A new platelet receptor specific to type III collagen. Type III collagen-binding protein.

Authors:  E Monnet; F Fauvel-Lafève
Journal:  J Biol Chem       Date:  2000-04-14       Impact factor: 5.157

2.  Genomic organization of the human COL3A1 and COL5A2 genes: COL5A2 has evolved differently than the other minor fibrillar collagen genes.

Authors:  M Välkkilä; M Melkoniemi; L Kvist; H Kuivaniemi; G Tromp; L Ala-Kokko
Journal:  Matrix Biol       Date:  2001-09       Impact factor: 11.583

3.  Structure of type I and type III heterotypic collagen fibrils: an X-ray diffraction study.

Authors:  G J Cameron; I L Alberts; J H Laing; T J Wess
Journal:  J Struct Biol       Date:  2002 Jan-Feb       Impact factor: 2.867

4.  Collagen remodeling and cardiac dysfunction in patients with hypertrophic cardiomyopathy: the significance of type III and VI collagens.

Authors:  M Kitamura; M Shimizu; H Ino; K Okeie; M Yamaguchi; N Funjno; H Mabuchi; I Nakanishi
Journal:  Clin Cardiol       Date:  2001-04       Impact factor: 2.882

5.  Aberrant type I and type III collagen gene expression in human breast cancer in vivo.

Authors:  S Kauppila; F Stenbäck; J Risteli; A Jukkola; L Risteli
Journal:  J Pathol       Date:  1998-11       Impact factor: 7.996

6.  The role of type III collagen in the development of familial abdominal aortic aneurysms.

Authors:  C J van Keulen; E van de Akker; G Pals; J A Rauwerda
Journal:  Eur J Vasc Endovasc Surg       Date:  1999-07       Impact factor: 7.069

7.  Characterization of 11 new mutations in COL3A1 of individuals with Ehlers-Danlos syndrome type IV: preliminary comparison of RNase cleavage, EMC and DHPLC assays.

Authors:  C Giunta; B Steinmann
Journal:  Hum Mutat       Date:  2000-08       Impact factor: 4.878

8.  Genetic variability in the extracellular matrix as a determinant of cardiovascular risk: association of type III collagen COL3A1 polymorphisms with coronary artery disease.

Authors:  Clare Muckian; Anthony Fitzgerald; Anne O'Neill; Anna O'Byrne; Desmond J Fitzgerald; Denis C Shields
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

9.  Comparative investigation on the influence of human and bovine collagen types I, II and III on the aggregation of human platelets.

Authors:  L Balleisen; S Gay; R Marx; K Kühn
Journal:  Klin Wochenschr       Date:  1975-10-01

10.  Patients with Ehlers-Danlos syndrome type IV lack type III collagen.

Authors:  F M Pope; G R Martin; J R Lichtenstein; R Penttinen; B Gerson; D W Rowe; V A McKusick
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

View more
  44 in total

1.  PTH/PTHrP Receptor Signaling Restricts Arterial Fibrosis in Diabetic LDLR-/- Mice by Inhibiting Myocardin-Related Transcription Factor Relays.

Authors:  Abraham Behrmann; Dalian Zhong; Li Li; Su-Li Cheng; Megan Mead; Bindu Ramachandran; Parastoo Sabaeifard; Mohammad Goodarzi; Andrew Lemoff; Henry M Kronenberg; Dwight A Towler
Journal:  Circ Res       Date:  2020-03-11       Impact factor: 17.367

2.  Targetable cellular signaling events mediate vascular pathology in vascular Ehlers-Danlos syndrome.

Authors:  Caitlin J Bowen; Juan Francisco Calderón Giadrosic; Zachary Burger; Graham Rykiel; Elaine C Davis; Mark R Helmers; Kelly Benke; Elena Gallo MacFarlane; Harry C Dietz
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

Review 3.  The extracellular matrix of hematopoietic stem cell niches.

Authors:  Cornelia Lee-Thedieck; Peter Schertl; Gerd Klein
Journal:  Adv Drug Deliv Rev       Date:  2021-11-25       Impact factor: 15.470

4.  An Integrated Bioinformatics Analysis towards the Identification of Diagnostic, Prognostic, and Predictive Key Biomarkers for Urinary Bladder Cancer.

Authors:  Michail Sarafidis; George I Lambrou; Vassilis Zoumpourlis; Dimitrios Koutsouris
Journal:  Cancers (Basel)       Date:  2022-07-10       Impact factor: 6.575

5.  Collagen- and hyaluronic acid-based hydrogels and their biomedical applications.

Authors:  Qinghua Xu; Jessica E Torres; Mazin Hakim; Paulina M Babiak; Pallabi Pal; Carly M Battistoni; Michael Nguyen; Alyssa Panitch; Luis Solorio; Julie C Liu
Journal:  Mater Sci Eng R Rep       Date:  2021-07-30       Impact factor: 33.667

6.  Neuregulin (NRG-1β) Is Pro-Myogenic and Anti-Cachectic in Respiratory Muscles of Post-Myocardial Infarcted Swine.

Authors:  Cristi L Galindo; Van Thuan Nguyen; Braxton Hill; Ethan Easterday; John H Cleator; Douglas B Sawyer
Journal:  Biology (Basel)       Date:  2022-04-29

7.  Molecular pathology of human knee arthrofibrosis defined by RNA sequencing.

Authors:  Banu Bayram; Afton K Limberg; Christopher G Salib; Jacob W Bettencourt; William H Trousdale; Eric A Lewallen; Nicolas Reina; Christopher R Paradise; Roman Thaler; Mark E Morrey; Joaquin Sanchez-Sotelo; Daniel J Berry; Andre J van Wijnen; Matthew P Abdel
Journal:  Genomics       Date:  2020-03-05       Impact factor: 5.736

8.  LncRNA H19 Regulates Proliferation, Apoptosis and ECM Degradation of Aortic Smooth Muscle Cells Via miR-1-3p/ADAM10 Axis in Thoracic Aortic Aneurysm.

Authors:  Zhineng Fan; Shuan Liu; Houqing Zhou
Journal:  Biochem Genet       Date:  2021-09-03       Impact factor: 1.890

9.  Identification of COL3A1 variants associated with sporadic thoracic aortic dissection: a case-control study.

Authors:  Yanghui Chen; Yang Sun; Zongzhe Li; Chenze Li; Lei Xiao; Jiaqi Dai; Shiyang Li; Hao Liu; Dong Hu; Dongyang Wu; Senlin Hu; Bo Yu; Peng Chen; Ping Xu; Wei Kong; Dao Wen Wang
Journal:  Front Med       Date:  2021-05-28       Impact factor: 4.592

Review 10.  Tissue-specific parameters for the design of ECM-mimetic biomaterials.

Authors:  Olivia R Tonti; Hannah Larson; Sarah N Lipp; Callan M Luetkemeyer; Megan Makam; Diego Vargas; Sean M Wilcox; Sarah Calve
Journal:  Acta Biomater       Date:  2021-04-18       Impact factor: 10.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.